These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34192856)

  • 21. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 22. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.
    Shiraishi T; Sasaki T; Ikeda K; Tsukada Y; Nishizawa Y; Ito M
    BMC Cancer; 2019 Dec; 19(1):1222. PubMed ID: 31842797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical intervention after neoadjuvant therapy in esophageal cancer: a narrative review.
    Ke J; Xie Y; Liang J; Wang M; Lin W
    J Thorac Dis; 2023 Apr; 15(4):2261-2276. PubMed ID: 37197518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
    Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
    Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.
    Barnes CA; Aldakkak M; Christians KK; Clarke CN; Dua K; George B; Ritch PS; Kamgar M; Hall WA; Kulkarni N; Erickson BA; Evans DB; Tsai S
    Surgery; 2020 Sep; 168(3):440-447. PubMed ID: 32641278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial.
    Tang H; Wang H; Fang Y; Zhu JY; Yin J; Shen YX; Zeng ZC; Jiang DX; Hou YY; Du M; Lian CH; Zhao Q; Jiang HJ; Gong L; Li ZG; Liu J; Xie DY; Li WF; Chen C; Zheng B; Chen KN; Dai L; Liao YD; Li K; Li HC; Zhao NQ; Tan LJ
    Ann Oncol; 2023 Feb; 34(2):163-172. PubMed ID: 36400384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 30. Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
    Okamura R; Itatani Y; Fujita Y; Hoshino N; Okumura S; Nishiyama K; Hida K; Obama K
    World J Surg Oncol; 2023 Aug; 21(1):247. PubMed ID: 37587422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biomarkers of predicting response to neoadjuvant chemoradiotherapy in esophageal cancer].
    Fu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):805-10. PubMed ID: 24061981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
    Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.
    Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P
    World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer.
    Hou S; Pan Z; Hao X; Hang Q; Ding Y
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study.
    He W; Wang C; Wu L; Wan G; Li B; Han Y; Li H; Leng X; Du K; Chen H; Wang Q; Peng L
    Front Immunol; 2022; 13():853922. PubMed ID: 35720312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study.
    Sun YW; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Wang XJ
    Gastroenterol Res Pract; 2017; 2017():5715219. PubMed ID: 28400820
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
    Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
    World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History and current situation of neoadjuvant treatment for locally advanced esophageal cancer.
    Li J; Ma S
    Thorac Cancer; 2021 Sep; 12(17):2293-2299. PubMed ID: 34254738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.